Adam JacksonOctober 5, 2023
The company's also trying to get into the de-buzzing game.
Tag: FSD Pharma
Adam JacksonOctober 5, 2023
StaffJuly 18, 2023
The Daily Hit is a recap of the top financial news stories for July 18, 2023. On The Site Deceased Worker From Green Thumb Industries Identified, Teamsters Call for Action A worker at Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF) who died while on the job Friday has been identified as 60-year-old Julie Devinney, whose sudden passing prompted […]
Adam JacksonJuly 18, 2023
FSD Pharma successfully countered a $4 million claim, but still had to cough up nearly half of that.
Debra BorchardtJuly 10, 2023Former CEO continues to take FSD Pharma to court.
Adam JacksonJune 21, 2023
The former CEO is seeking more than $30 million in damages.
Debra BorchardtMay 10, 2023
In preclinical models, Lucid-MS has been shown to prevent a hallmark pathology feature of MS.
Debra BorchardtJuly 30, 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN)announced that it has notified Health Canada of the company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma said it has begun the process of liquidating all FV Pharma assets, including […]
StaffJune 22, 2020
Canadian licensed producer FSD Pharma Inc. (Nasdaq: HUGE) has made a pivot in order to assist in the treatment of the deadly COVID-19 virus. The company announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide (PEA), or FSD201. The company is hoping that with positive Phase 2 results, it […]
Video StaffJanuary 13, 2020
FSD Pharma Inc. (NASDAQ: HUGE) became the latest company to list on the NASDAQ Marketsite. Green Market Report spoke with CEO Raza Bokhari the day the stock began trading using the symbol HUGE. This video is edited for time.
Debra BorchardtJuly 2, 2019
R&D pharmaceutical company FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) finalized its acquisition of Prismic in a deal valued at approximately $17.5 million or C$23.4 million. The company said that the deal will be satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma at a […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.